These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands. Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485 [TBL] [Abstract][Full Text] [Related]
4. Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT Edgar FG; Hansen HD; Leth-Petersen S; Ettrup A; Kristensen JL; Knudsen GM; Herth MM J Labelled Comp Radiopharm; 2017 Oct; 60(12):586-591. PubMed ID: 28856700 [TBL] [Abstract][Full Text] [Related]
5. In vivo evaluation of [ Prabhakaran J; Solingapuram Sai KK; Zanderigo F; Rubin-Falcone H; Jorgensen MJ; Kaplan JR; Tooke KI; Mintz A; Mann JJ; Kumar JSD Bioorg Med Chem Lett; 2017 Jan; 27(1):21-23. PubMed ID: 27889455 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors. Prabhakaran J; Underwood MD; Kumar JS; Simpson NR; Kassir SA; Bakalian MJ; Mann JJ; Arango V Bioorg Med Chem Lett; 2015 Sep; 25(18):3933-6. PubMed ID: 26253634 [TBL] [Abstract][Full Text] [Related]
7. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET. Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470 [TBL] [Abstract][Full Text] [Related]
8. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET. Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031 [TBL] [Abstract][Full Text] [Related]
9. (11)C-labeling and preliminary evaluation of pimavanserin as a 5-HT2A receptor PET-radioligand. Andersen VL; Hansen HD; Herth MM; Dyssegaard A; Knudsen GM; Kristensen JL Bioorg Med Chem Lett; 2015 Mar; 25(5):1053-6. PubMed ID: 25655720 [TBL] [Abstract][Full Text] [Related]
10. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers. Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090 [TBL] [Abstract][Full Text] [Related]
11. Iodonium ylide-mediated radiofluorination of 18F-FPEB and validation for human use. Stephenson NA; Holland JP; Kassenbrock A; Yokell DL; Livni E; Liang SH; Vasdev N J Nucl Med; 2015 Mar; 56(3):489-92. PubMed ID: 25655630 [TBL] [Abstract][Full Text] [Related]
12. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin. Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and in vivo evaluation of [O-methyl-11C](2R,4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy)phenyl]ethyl]phenoxy]ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand. Kumar JS; Prabhakaran J; Erlandsson K; Majo VJ; Simpson NR; Pratap M; Van Heertum RL; Mann JJ; Parsey RV Nucl Med Biol; 2006 May; 33(4):565-74. PubMed ID: 16720250 [TBL] [Abstract][Full Text] [Related]
15. Classics in Neuroimaging: The Serotonergic 2A Receptor System-from Discovery to Modern Molecular Imaging. T L'Estrade E; Hansen HD; Erlandsson M; Ohlsson TG; Knudsen GM; Herth MM ACS Chem Neurosci; 2018 Jun; 9(6):1226-1229. PubMed ID: 29763291 [TBL] [Abstract][Full Text] [Related]
16. Time-efficient and convenient synthesis of [(18)F]altanserin for human PET imaging by a new work-up procedure. Massarweh G; Kovacevic M; Rosa-Neto P; Evans AC; Diksic M; Schirrmacher R Appl Radiat Isot; 2009 Nov; 67(11):2040-3. PubMed ID: 19692252 [TBL] [Abstract][Full Text] [Related]
17. Facile Liang SH; Wang L; Stephenson NA; Rotstein BH; Vasdev N Nat Protoc; 2019 May; 14(5):1530-1545. PubMed ID: 30980032 [TBL] [Abstract][Full Text] [Related]
18. Total synthesis and evaluation of [18F]MHMZ. Herth MM; Debus F; Piel M; Palner M; Knudsen GM; Lüddens H; Rösch F Bioorg Med Chem Lett; 2008 Feb; 18(4):1515-9. PubMed ID: 18187324 [TBL] [Abstract][Full Text] [Related]
19. Rational Design, Pharmacomodulation, and Synthesis of Dual 5-Hydroxytryptamine 7 (5-HT7)/5-Hydroxytryptamine 2A (5-HT2A) Receptor Antagonists and Evaluation by [(18)F]-PET Imaging in a Primate Brain. Deau E; Robin E; Voinea R; Percina N; Satała G; Finaru AL; Chartier A; Tamagnan G; Alagille D; Bojarski AJ; Morisset-Lopez S; Suzenet F; Guillaumet G J Med Chem; 2015 Oct; 58(20):8066-96. PubMed ID: 26348247 [TBL] [Abstract][Full Text] [Related]
20. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain. Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]